Rayno Life Science Stocks Update and MO Watch: ARRY, INFI, MDVN, PCYC Update 1
Rayno Biopharmaceutical Stocks In a Stealth Rally-Most Core Positions Up No changes have been made in core portfolio positions except as noted below. See update in Seeking Alpha. Action today with strong charts since Feb 26 Sell-Off ALXN ($93) stable and recovering off 1 month lows BIIB ($178)...
Rayno Medical Diagnostics Universe: Financial Metrics
Rayno DX Focus stocks are ABAX, ALR, CPHD, EXAS, GHDX, NEOG, QGEN, QDEL, RGDX, SQNM. New Highs in Q1: ABAX, NEOG, QDEL, TMO Company Ticker Price Rev Q4 Rev Price 2011 P/S PE PEG SE Mcap May'11 2012 yr 2012 21-Mar Rev P/B $B GenProbe* GPRO 80 642 143 sold 66 576 5 64 1.9 700 Abaxis ABAX...
MO Stock Watch: AMZN, NFLX, INFI, ISRG, MDVN, PCYC–Update 3/15
Technicals Matter in a MOmentum Market Some important trends are developing in momentum stocks some of which are on in our Life Science Portfolio. As we have written previously many momentum stocks are being driven by media buzz, novel business models and sponsorship from hedge funds and growth...
Rayno Life Science Winners on a Quiet Day
Big Movers on a Blah Day Abaxis (ABAX $45.87) all time high. Albany Molecular (AMRI $10.41) 3 year high, outlook up Alere (ALR $24.17) laggard value stock with novel health information strategy Cardiovascular Systems (CSII $19.03) up 15.33% Sequenom (SQNM $4.53) up 5%, Q4 Sales hit $33M New...